Open Access

Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts

  • Authors:
    • Gary Tse
    • Bing Sun
    • Sheung Ting Wong
    • Vivian Tse
    • Jie Ming Yeo
  • View Affiliations

  • Published online on: August 2, 2016     https://doi.org/10.3892/br.2016.735
  • Pages: 301-310
  • Copyright : © Tse et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study examined the ventricular arrhythmic and electrophysiological properties during hyperkalemia (6.3 mM [K+] vs. 4 mM in normokalemia) and anti‑arrhythmic effects of hypercalcemia (2.2 mM [Ca2+]) in Langendorff‑perfused mouse hearts. Monophasic action potential recordings were obtained from the left ventricle during right ventricular pacing. Hyperkalemia increased the proportion of hearts showing provoked ventricular tachycardia (VT) from 0 to 6 of 7 hearts during programmed electrical stimulation (Fisher's exact test, P<0.05). It shortened the epicardial action potential durations (APDx) at 90, 70, 50 and 30% repolarization and ventricular effective refractory periods (VERPs) (analysis of variance, P<0.05) without altering activation latencies. Endocardial APDx and VERPs were unaltered. Consequently, ∆APDx (endocardial APDx‑epicardial APDx) was increased, VERP/latency ratio was decreased and critical intervals for reexcitation (APD90‑VERP) were unchanged. Hypercalcemia treatment exerted anti‑arrhythmic effects during hyperkalemia, reducing the proportion of hearts showing VT to 1 of 7 hearts. It increased epicardial VERPs without further altering the remaining parameters, returning VERP/latency ratio to normokalemic values and also decreased the critical intervals. In conclusion, hyperkalemia exerted pro‑arrhythmic effects by shortening APDs and VERPs. Hypercalcemia exerted anti‑arrhythmic effects by reversing VERP changes, which scaled the VERP/latency ratio and critical intervals.
View Figures
View References

Related Articles

Journal Cover

September-2016
Volume 5 Issue 3

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tse G, Sun B, Wong ST, Tse V and Yeo JM: Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts. Biomed Rep 5: 301-310, 2016.
APA
Tse, G., Sun, B., Wong, S.T., Tse, V., & Yeo, J.M. (2016). Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts. Biomedical Reports, 5, 301-310. https://doi.org/10.3892/br.2016.735
MLA
Tse, G., Sun, B., Wong, S. T., Tse, V., Yeo, J. M."Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts". Biomedical Reports 5.3 (2016): 301-310.
Chicago
Tse, G., Sun, B., Wong, S. T., Tse, V., Yeo, J. M."Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts". Biomedical Reports 5, no. 3 (2016): 301-310. https://doi.org/10.3892/br.2016.735